ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994

Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says

July 18, 1986

Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level

July 2, 1999

Orphan Designation Granted To Advaxis HPV Immunotherapy

May 30, 2014

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

Former kidney cancer advocate Carl Dixon charged with theft of $335,000 from association.

October 3, 2003